|Day's Range||7.40 - 7.63|
|52 Week Range||2.35 - 8.72|
|PE Ratio (TTM)||-297.20|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On a per-share basis, the Montreal-based company said it had a loss of 10 cents. The metabolic disorder drug company posted revenue of $7.4 million in the period. Theratechnologies shares have more than ...
Q2 2017 Theratechnologies Inc Earnings Call
Q1 2017 Theratechnologies Inc Earnings Call